Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Special cell particles from macrophages can help hair grow.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Stem cells, especially from fat tissue and Wharton's jelly, can potentially regenerate hair follicles and treat hair loss, but more research is needed to perfect the treatment.

Anti-TNF therapy can cause hair loss and skin issues.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

Hair loss in lupus patients indicates higher disease activity.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

DPCP is effective for treating severe alopecia areata, but relapse is common.

Conditioned medium from keratinocytes can improve hair growth potential in cultured dermal papilla cells.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

Fat under the skin releases HGF which helps hair grow and gain color.

Bone-forming cells grow well in 3D polymer scaffolds with 35 µm pores.

Bioengineering can potentially treat hair loss by regenerating hair follicles and cloning hair, but the process is complex and needs more research.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

The report found a new type of hair loss in African-American women that affects more areas of the scalp than previously thought.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

Heat treatment increases hair loss in certain mice.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Many women with hair loss also have thyroid issues, high blood pressure, and low Vitamin D.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Nivolumab can cause hair loss as a rare side effect.

Diphencyprone can cause unexpected and possibly permanent vitiligo.